Literature DB >> 19085117

Peptide-based delivery of steric-block PNA oligonucleotides.

Saïd Abes1, Gabriela D Ivanova, Rachida Abes, Andrey A Arzumanov, Donna Williams, David Owen, Bernard Lebleu, Michael J Gait.   

Abstract

Several strategies based on synthetic oligonucleotides (ON) have been proposed to control gene expression. As for most biomolecules, however, delivery has remained a major roadblock for in vivo applications. Conjugation of steric-block neutral DNA mimics such as peptide nucleic acids (PNA) or phosphorodiamidate morpholino oligonucleotides (PMO) to cell penetrating peptides (CPP) has recently been proposed as a new delivery strategy. It is particularly suitable to interfere sequence-specifically with pre-mRNA splicing thus offering various applications in fundamental research and in therapeutics. The chemical synthesis of these CPP conjugates as well as methodologies to monitor their cellular uptake and their efficiency in a reliable and easy to implement assay of splicing correction will be described.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19085117     DOI: 10.1007/978-1-59745-429-2_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.

Authors:  Indrajit Das; Jérôme Désiré; Dinesh Manvar; Isabelle Baussanne; Virendra N Pandey; Jean-Luc Décout
Journal:  J Med Chem       Date:  2012-06-22       Impact factor: 7.446

Review 2.  Macromolecular drug delivery: basic principles and therapeutic applications.

Authors:  Mattias Belting; Anders Wittrup
Journal:  Mol Biotechnol       Date:  2009-05-28       Impact factor: 2.695

Review 3.  Non-natural nucleic acids for synthetic biology.

Authors:  Daniel H Appella
Journal:  Curr Opin Chem Biol       Date:  2009-10-29       Impact factor: 8.822

Review 4.  Prospects for antisense peptide nucleic acid (PNA) therapies for HIV.

Authors:  Virendra N Pandey; Alok Upadhyay; Binay Chaubey
Journal:  Expert Opin Biol Ther       Date:  2009-08       Impact factor: 4.388

5.  Inactivation of expression of several genes in a variety of bacterial species by EGS technology.

Authors:  Ning Shen; Jae-hyeong Ko; Gaoping Xiao; Donna Wesolowski; Ge Shan; Bruce Geller; Mina Izadjoo; Sidney Altman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-30       Impact factor: 11.205

Review 6.  Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?

Authors:  Babak Kateb; Katherine Chiu; Keith L Black; Vicky Yamamoto; Bhavraj Khalsa; Julia Y Ljubimova; Hui Ding; Rameshwar Patil; Jose Antonio Portilla-Arias; Mike Modo; David F Moore; Keyvan Farahani; Michael S Okun; Neal Prakash; Josh Neman; Daniel Ahdoot; Warren Grundfest; Shouleh Nikzad; John D Heiss
Journal:  Neuroimage       Date:  2010-02-10       Impact factor: 7.400

7.  Peptide nanoparticle delivery of charge-neutral splice-switching morpholino oligonucleotides.

Authors:  Peter Järver; Eman M Zaghloul; Andrey A Arzumanov; Amer F Saleh; Graham McClorey; Suzan M Hammond; Mattias Hällbrink; Ülo Langel; C I Edvard Smith; Matthew J A Wood; Michael J Gait; Samir El Andaloussi
Journal:  Nucleic Acid Ther       Date:  2015-01-16       Impact factor: 5.486

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.